NCT04160910View on ClinicalTrials.gov

5HTP Regulation Of Asthma In Children

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

January 5, 2026

Study Completion Date

January 5, 2026

Conditions
Mild or Moderate Asthma With Allergic Sensitization
Interventions
DRUG

5-Hydroxytryptophan

Double blinded placebo controlled. 28 day dosing period followed by 3 week washout period. Then crossover to other arm of study

DRUG

Placebo

Double blinded placebo controlled. 28 day dosing period followed by 3 week washout period. Then crossover to other arm of study

Trial Locations (1)

46202

RECRUITING

Indiana University, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER